Brief: Auris Medical Says Outbreak Has Delayed Enrollment Into Phase 2 Trial With AM-125

Altamira Therapeutics

03/04/2020 22:05

April 3 (Reuters) - Auris Medical Holding Ltd  EARS.O :
    * AURIS MEDICAL PROVIDES UPDATE ON INTRANASAL BETAHISTINE
DEVELOPMENT PROGRAM
    * AURIS MEDICAL HOLDING LTD - PHASE 1B TRIAL WITH AM-201
PROCEEDING AS PLANNED TO DATA READ-OUT IN EARLY MAY 2020
    * AURIS MEDICAL HOLDING LTD - ENROLLMENT INTO PHASE 2 TRIAL
WITH
AM-125 IMPACTED BY COVID-19 PANDEMIC
    * AURIS MEDICAL HOLDING LTD -  OUTBREAK HAS DELAYED
ENROLLMENT
INTO PHASE 2 TRIAL WITH AM-125
    * AURIS MEDICAL HOLDING LTD - ENROLLMENT IN STUDY CAME TO A
HALT
TOWARDS END OF MARCH 2020
    * AURIS MEDICAL HOLDING LTD - EXPECTS THAT INTERIM ANALYSIS
FOLLOWING PART A OF TRIAL WILL NOW BE COMPLETED IN Q3 OF 2020,
AT EARLIEST

Source text for Eikon:  ID:nGNX17yxrp 
Further company coverage:  EARS.O 

 ((Reuters.Briefs@thomsonreuters.com;))